DUBLIN, Sep 01, 2010 (BUSINESS WIRE) --

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the agenda for its investor meeting on Wednesday, September 15, 2010. The event will be held at The Plaza Hotel, Fifth Avenue at Central Park South, New York, NY. A webcast of the presentations will begin at 12:00 pm and the webcast will conclude by 5:00 pm.

The program will include presentations by Covidien's Chairman, President and CEO Richard J. Meelia and other members of the senior management team, including the leaders of each of Covidien's three business segments. For those investors who are unable to attend the meeting in person, but who would like to ask a question of the management team during the meeting, questions can be emailed to


10:00 am Registration Opens
10:15 am Product Displays and Senior Management Reception
12:00 pm Presentations begin
-- Richard J. Meelia, Chairman, President and CEO
-- James C. Clemmer, President, Medical Supplies
-- Timothy R. Wright, President, Pharmaceuticals
-- José (Joe) E. Almeida, President, Medical Devices
-- Joseph Woody, President, Vascular Therapies
4:00 pm Charles J. Dockendorff, Chief Financial Officer
5:00 pm Presentations and webcast end

Advanced registration is required and attendance will be limited to those who register in advance. To register for the meeting, please go to the following website:

Individuals who are unable to attend the meeting in person will be able to view a live video and webcast at Covidien's website: A replay of the presentations and the presentation materials will be available at the same website following the conclusion of the meeting.


Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2009 revenue of $10.3 billion, Covidien has 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit to learn more about our business.